Learn
GROWTH
Molecule Ventures Limited Liability Partnership
886.98 CR AUM
GROWTH
Molecule Ventures Limited Liability Partnership
886.98 CR AUM
BSE 500 TRI
Benchmark
4yr 10mo
Age
EQUITY
Strategy
NIL
Fixed Fees
Profit Sharing:20%
Variable Fees
NIL
Exit Load
BSE 500 TRI
Benchmark
4yr 10mo
Age
EQUITY
Strategy
NIL
Fixed Fees
Profit Sharing:20%
Variable Fees
NIL
Exit Load
nirav parikh
Fund Manager
EQUITYStrategies
Nirav Parikh has a rich investing experience of 16 years in Small and Mid size companies. He has in past worked with Ghalla Bhansali, Reliance equities, Alchemy Capital covering various sectors. He holds an MBA from NMIMS, Mumbai and is a Graduate in Commerce from Mumbai University. He is also CFA Charter holder (US) and FRM.
Purpose
The primary objective of the fund is to achieve capital appreciation through medium to long term investments in quality companies with strong growth prospects, mostly in the Mid and Small Cap.
Investment Approach v/s Benchmark Metrics
Loading
Unlock all metrics
Login to see the live performance and return
Wealth Creation Calculator
1M IA return
25.31%
1M benchmark return
10.38%
Alpha
14.93%
1M Wealth multiple
1.25x
Investment Approach v/s Benchmark Performance
2026
2026
Loading
Unlock all metrics
Login to see the live performance and return
Wealth Creation Calculator
1M IA return
25.31%
1M benchmark return
10.38%
Alpha
14.93%
1M Wealth multiple
1.25x
Similar Investment Approaches
Enam India Equity Portfolio
Enam Asset Management Company Private Limited
₹21,139.54 Cr
EQ
Customised Discretionary Portfolio - Equity
360 One Asset Management Limited
₹17,979.78 Cr
EQ
Q India Value Equity Strategy - Constrained V
Quantum Advisors Private Limited
₹15,759.81 Cr
EQ
Icici Prudential Pms Contra Strategy
Icici Prudential Asset Management Company Ltd
₹13,391.43 Cr
EQ
Blended- Rangoli
Unifi Capital P Ltd
₹11,765.52 Cr
EQ